Giant Biogene Holding Co (HKSE:02367) EV-to-EBIT : 23.70 (As of May. 05, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Giant Biogene Holding Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Giant Biogene Holding Co's Enterprise Value is HK$45,249 Mil. Giant Biogene Holding Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,909 Mil. Therefore, Giant Biogene Holding Co's EV-to-EBIT for today is 23.70.

The historical rank and industry rank for Giant Biogene Holding Co's EV-to-EBIT or its related term are showing as below:

HKSE:02367' s EV-to-EBIT Range Over the Past 10 Years
Min: 13.93 Med: 24.93 Max: 43.29
Current: 23.7

During the past 5 years, the highest EV-to-EBIT of Giant Biogene Holding Co was 43.29. The lowest was 13.93. And the median was 24.93.

HKSE:02367's EV-to-EBIT is ranked worse than
72.62% of 1468 companies
in the Consumer Packaged Goods industry
Industry Median: 14.1 vs HKSE:02367: 23.70

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Giant Biogene Holding Co's Enterprise Value for the quarter that ended in Dec. 2023 was HK$30,826 Mil. Giant Biogene Holding Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,909 Mil. Giant Biogene Holding Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 6.19%.

Giant Biogene Holding Co EV-to-EBIT Historical Data

The historical data trend for Giant Biogene Holding Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Giant Biogene Holding Co EV-to-EBIT Chart

Giant Biogene Holding Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

23.56

16.15

Giant Biogene Holding Co Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial			-	-	23.56	-	16.15

Competitive Comparison of Giant Biogene Holding Co's EV-to-EBIT

For the Household & Personal Products subindustry, Giant Biogene Holding Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Giant Biogene Holding Co's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Giant Biogene Holding Co's EV-to-EBIT falls into.

Giant Biogene Holding Co EV-to-EBIT Calculation

Giant Biogene Holding Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	45248.601	/	1908.865
	=	23.70

Giant Biogene Holding Co's current Enterprise Value is HK$45,249 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Giant Biogene Holding Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,909 Mil.

Giant Biogene Holding Co (HKSE:02367) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Giant Biogene Holding Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	1908.865	/	30825.8988
	=	6.19 %

Giant Biogene Holding Co's Enterprise Value for the quarter that ended in Dec. 2023 was HK$30,826 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Giant Biogene Holding Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,909 Mil.

Giant Biogene Holding Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Giant Biogene Holding Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Giant Biogene Holding Co (HKSE:02367) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Giant Biogene Holding Co Ltd (HKSE:02367) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN

Website

http://www.xajuzi.com

Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.

Giant Biogene Holding Co (HKSE:02367) Headlines

No Headlines